LRMR
Larimar Therapeutics, Inc. · Healthcare
* Director by Deputization, 10% James E Flynn bought $6.0M of Larimar Therapeutics, Inc.
Bought$5,999,963
$8.75Price
685,710Shares
+13%Stake
What LRMR did for a copier
- $1,000 copied at Tue, Jul 6 open, $11.24
- $1,204
- S&P 500, same days
- +2.4%
Measured over 30 trading days, to the Aug 17 close.
James E Flynn's record
8 other buys with 3 months of prices since 2016: on average −17.1% against the S&P 500, and 1 of 8 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Jun 30. Filed Fri, Jul 2, 5:07 PM ET, after the close. Returns use the Jul 6 open and the Aug 17 close. Not investment advice.